An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Grants Isturisa® (Osilodrostat) Expanded Indication for the Treatment of Enodogenous Hypercortisolemia in Patients with Cushing’s Syndrome On April 15, Recordati announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for ISTURISA® (osilodrostat) for...
Author: Mark Newman
A recent study entitled “Association Between Per- and Polyfluoroalkyl Substance Exposures and Thyroid Homeostasis Parameters,” published in the Journal of Clinical Endocrinology & Metabolism, has found that exposure to per- and polyfluoroalkyl substances (PFAS) — a group of synthetic chemicals used in industrial and consumer products — may alter thyroid hormone sensitivity, potentially affecting metabolism...
Just when you thought it was time to roll up the red carpet, four Endocrine Society members have recently been announced as taking home their fair share of prestigious awards that recognize outstanding leaders in research and science. First off, the 2025 Breakthrough Prize for Life Science has been presented to Daniel J. Drucker, MD,...
The World Health Organization reports that obesity affects one in eight people globally, making it a major public issue. Yet obesity is not just about diet, exercise, and genes — something else must be afoot. Recently, evidence has pointed to an invisible but powerful culprit: dioxins and dioxin-like polychlorinated diphenyls (DL-PCBs), according to “Association Between...
Silent Disruptors: How Environmental Chemicals Threaten Thyroid Health and Development
It is well documented that endocrine-disrupting chemicals (EDCs) are virtually inescapable in everyday life since they are present in everything from food packaging and clothing to flame retardants toys. An upcoming ENDO 2025 session, “Thyroid Disruptors,” examines how EDCs affect thyroid function in pregnancy, childhood, and the link to an increased thyroid cancer risk in...
Smarter Diagnosis: AI Enhances Clinical Assessment of Hypercortisolism
Doctor AI will see you now — eventually. A new study from The Journal of Clinical Endocrinology & Metabolism has demonstrated how artificial intelligence (AI) can enhance the accuracy of diagnosing Cushing’s syndrome (CS), a rare but serious endocrine disorder caused by excessive cortisol production. Cushing’s syndrome is characterized by a broad spectrum of symptoms,...
Endocrine Society Advocates to Protect Funding for NIH and Reauthorize SDP on Capitol Hill On Wednesday, March 12, the Endocrine Society hosted a Researcher Hill Day and brought members from across the country to Washington, D.C., to meet with their senators and representatives and discuss the importance of completing the appropriations process for Fiscal Year...
The Endocrine Society is extremely disappointed the administration has chosen not to finalize a rule that would have made anti-obesity medications more accessible to millions of Americans with obesity. The administration decided not to implement a proposal that would have allowed Medicare and Medicaid to cover anti-obesity medications for weight loss. Many Medicare and Medicaid...
